Alex Zhavoronkov
banner
elonverse.bsky.social
Alex Zhavoronkov
@elonverse.bsky.social
My only objective function is to extend productive longevity for everyone on the planet. Here to share research papers. https://x.com/biogerontology
Reposted by Alex Zhavoronkov
Thanks to @sebastian.bsky.social for the great interview for the @newquantumera.com We talked about #GQE and #VQE and #QML #quantummachinelearning #quantum #compchemsky
January 21, 2025 at 2:20 AM
Reposted by Alex Zhavoronkov
Excited to share our latest work, published this morning in Nature Biotechnology! 🎉 We developed a hybrid quantum computing-enhanced generative model to design KRAS inhibitors. Check it out here: rdcu.be/d68Fs.

Some fascinating insights along the way:
January 22, 2025 at 8:17 PM
Reposted by Alex Zhavoronkov
Part 1: Exciting news! Our research on quantum drug discovery is now in Nature Biotechnology. A Quantum Computer helped design KRAS inhibitors, an elusive cancer target. These inhibitors were successfully synthesized and tested, marking a milestone in healthcare innovation. 🚀
#QuantumComputing #KRAS
January 22, 2025 at 7:59 PM
Reposted by Alex Zhavoronkov
Glad to see our research on thr first #quantum + #ai application with experimental confirmation for #drugdiscovery out in Nature Biotechnology!

@ghazivakili.bsky.social @elonverse.bsky.social Igor Stagljar @thematterlab.bsky.social
January 22, 2025 at 9:12 PM
Another day, another paper -- and this research paper paves the way to a therapeutic program with very real therapeutic opportunity. Welcome our new paper with CUHK titled "Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis"
January 17, 2025 at 9:48 PM
And now, many of my friends with PRMT5 inhibitors in their pipelines will take notice. Welcome the new paper from University of Chicago Evgeny Izumchenko's group showing that PRMT5is can serve as powerful agents in adenoid cystic carcinoma of salivary glands.
January 17, 2025 at 4:01 AM
Huge congratulations to Dominika Wilczok on her first single author paper on generative AI for aging research. This paper has over 170 references and is a gargantuan amount of work.
www.aging-us.com/article/2061...
January 17, 2025 at 3:45 AM
Reposted by Alex Zhavoronkov
If you don't have quantitative benchmarks, you can not improve. Check out Domika Wilczok's paper on challenges in AI pharma R&D
ascpt.onlinelibrary.wiley.com/doi/full/10....
Progress, Pitfalls, and Impact of AI‐Driven Clinical Trials
Since the deep learning revolution of the early 2010s, significant efforts and billions of dollars have been invested in applying artificial intelligence (AI) to drug discovery and development (AIDD)....
ascpt.onlinelibrary.wiley.com
January 5, 2025 at 9:18 AM
Don't forget to read about the best device to measure your skin over time in the context of your daily life.
Thousands of meta clinical trials worldwide now.
onlinelibrary.wiley.com/doi/10.1111/...
Skinly: A novel handheld IoT device for validating biophysical skin characteristics
Background Recent advancements in artificial intelligence have revolutionized dermatological diagnostics. These technologies, particularly machine learning (ML), including deep learning (DL), have s.....
onlinelibrary.wiley.com
January 5, 2025 at 7:55 AM
1/ 🚨 Breakthrough in IBD treatment! Insilico Medicine's AI-developed gut-restricted PHD inhibitor, ISM012-042, offers a novel solution for intestinal inflammation and mucosal barrier repair. 🚀 Read on for key findings from the latest @NatureBiotech study. 🧵
December 15, 2024 at 5:31 AM
The 12th ARDD will transpire 25-29th of August, 2025 - mark your calendars for the largest aging research biotechnology conference on the planet!
December 15, 2024 at 5:29 AM